Trading The Discount: A Rules-Based Approach To Digital Asset Treasury Stocks
Strategy, BitMine, Sharplink and Hyperliquid Strategies traded at 14% to 33% discounts to token NAV on November 18, 2026, testing buy-wide, sell-narrow discount rules.
Strategy, BitMine, Sharplink and Hyperliquid Strategies traded at 14% to 33% discounts to token NAV on November 18, 2026, testing buy-wide, sell-narrow discount rules.
Bath & Body Works CEO Says Turnaround Progressing But Incomplete $BBWI
sold to $BSP Intuit to Sell Mailchimp for $3.68 Billion
Gap Cuts Outlook After Warm Fall Weather Weighs on Sales $GAP
TPG, Corpay to Buy Finance Platform BILL for About $6 Billion $BILL
Nice win for $EVC's Smadex
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
Daiichi Sankyo’s 43% share-price decline leaves Enhertu’s $4.98 billion FY2025 sales and Datroway’s launch supporting a lower-valued…
November purchases include Public Storage preferred shares and MercadoLibre, with a focus on preferred-stock income and Latin American…
Rick Rule argues copper needs $250 billion of capital and says 30-year uranium contracts are reshaping mine financing.
AST SpaceMobile’s 79% decline improves its risk-reward case, but satellite deployment delays, rising costs and Blacklift commitments raise…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Intel’s data-center growth reached 78% as Xeon capacity expands, while weak PC demand, foundry losses and capital spending pressure margins…
Netflix’s $20 billion 2026 content budget spreads fixed costs across 325 million members, but generative AI and content abundance threaten…
Everpure and Palo Alto Networks posted their largest sales upside in years, alongside a chip-company rejuvenation.
KRYS · short Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…
Synopsys and Cadence retain EDA pricing power through entrenched design flows, foundry relationships and high switching costs; AI-driven…
AI capex rests on coding-centric benchmarks, cheap-model commoditization and circular financing: OpenAI’s $60 billion annual Oracle…
Groupon is building an AI “Brain” to personalize its app for each user, turning its turnaround plan into a product initiative.
PostGPT inference-chip contenders need to run trillion-parameter models, ship rack-scale systems, beat GPUs on one KPI and win a frontier…
PayPal faces a $60.50-per-share buyout offer from Stripe and Advent, with a rejection or counteroffer above $80 viewed as more likely.
Lumentum’s InP DFB laser design for co-packaged optics traces to 2007 work and faces heat, linewidth, light-extraction and optical-damage…
Rebound Capital's July 2026 watchlist puts AeroVironment and Coinbase under review after UnitedHealth rose more than 70% from its low.
Airbnb spent 1.1% of 2025 GBV on field operations and policy as regulatory costs persisted; New York’s short-term-rental crackdown cut…
CBIZ activist Ryan Bunn urges ending buybacks, issuing equity and resuming bolt-on acquisitions to delever after the $2.3 billion Marcum…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.